GRIFOLS reported €771.1M in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Alcon AG ALC:SW 908M 18M
Amadeus IT AMS:SM € 145.2M 43.2M
Amarin AMRN:US $ 30.21M 1.94M
AstraZeneca AZN:LN 3824M 1631M
Bayer BAYN:GR € 3887M 659M
Fresenius FRE:GR € 6801M 173M
Fresenius Medical Care FME:GR € 3174M 137.82M
GlaxoSmithKline GSK:LN 2822M 303M
GRIFOLS GRF:SM € 771.1M 119.7M
H. Lundbeck A/S LUN:DC 851M 0
Hikma Pharmaceutical HIK:LN 600M 2M
Inditex ITX:SM € 3049M 1069M
Merck MRK:GR € 1859M 46M
Novartis NOVN:VX SF 3848M 94M
Philips PHIA:NA € 2182M 259M
William Demant Holding WDH:DC 2.29B 12M